Bain Capital emerges as sole contender to buy Vitabiotics after rivals exit bidding

Published on 24 April 2026

Rivals walk away, and the deal value may drop sharply

Bain Capital has become the frontrunner to acquire Vitabiotics after TPG Capital and EQT exited the bidding process. The move could reduce the company’s expected valuation of about £900 million. Vitabiotics, founded in 1971, is the UK’s largest multivitamin maker and sells across markets including India and China, with its India business contributing around 20% of revenue.

Bain Capital is now the leading bidder for Vitabiotics
TPG Capital and EQT have exited the acquisition process
The expected valuation around £900 million may face downward pressure
India operations drive roughly 20% of Vitabiotics revenue

#private equity #m and a #healthcare #vitabiotics #india

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

Bain Capital emerges as sole contender to buy Vitabiotics after rivals exit bidding

The full experience is on mobile.